Development and Validation of a Rapid Liquid Chromatography–Tandem Mass Spectrometry Method for the Quantitation of Vitamin K Metabolites in Different Matrices
Journal of Mass Spectrometry · 2025
DOI: 10.1002/jms.5120 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Mass Spectrometry, 2025. Verfasst von Danchen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Vitamin K. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National High-Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Adequate vitamin K is crucial for optimal health. Although vitamin K detection methods have been established using liquid chromatography–tandem mass spectrometry (LC–MS/MS), some limitations remain. Therefore, we aimed to establish a stable and rapid LC–MS/MS method that can quantify phylloquinone (VK1), menaquinones‐4 (MK‐4), and menaquinones‐7 (MK‐7) in serum and cerebrospinal fluid and explore its clinical applications. We developed an LC–MS/MS method with atmospheric pressure chemical ionization to quantify and validate its performance according to Clinical Laboratory and Standard Institution standards (C62‐Ed2). Serums from 50 healthy individuals and cerebrospinal fluid from 15 patients were collected for clinical application. Sample preparation involved lipase incubation, protein precipitation with ethanol, and liquid–liquid extraction with hexane/ethyl; optimization was performed for sample preparation and LC separation. Linearity was 50–10 000 pg/mL for VK1, MK‐4, and MK‐7. The total coefficient of variation (%) for VK1, MK‐4, and MK‐7 ranged from 8.5% to 10.4%, 8.0% to 10.4%, and 7.0% to 11.1%, respectively. Recovery of VK1, MK‐4, and MK‐7 was 82.3%–110.6%, 92.3%–110.6%, and 89.5%–117.8%, respectively. VK1 and MK‐7 were detected in the serum of all 50 healthy subjects, whereas MK‐4 was detected in only 13 (26%) subjects. Approximately 53.3% (8/15) had no detectable vitamin K in their cerebrospinal fluid. The developed method exhibited satisfactory performance and was applicable for detecting VK1, MK‐4, and MK‐7 in serum and cerebrospinal fluid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
ORCID-Profile: Danchen Wang
Förderung
- National Key Research and Development Program of China
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Wang, D., Ma, Y., Li, H., Ma, X., Zou, Y., Yu, S., & Qiu, L. (2025). Development and Validation of a Rapid Liquid Chromatography–Tandem Mass Spectrometry Method for the Quantitation of Vitamin K Metabolites in Different Matrices. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.5120
Vancouver
Wang D, Ma Y, Li H, Ma X, Zou Y, Yu S, et al. Development and Validation of a Rapid Liquid Chromatography–Tandem Mass Spectrometry Method for the Quantitation of Vitamin K Metabolites in Different Matrices. Journal of Mass Spectrometry. 2025. doi:10.1002/jms.5120
BibTeX
@article{Wang2025,
author = {Wang, Danchen and Ma, Yichen and Li, Honglei and Ma, Xiaoli and Zou, Yutong and Yu, Songlin and Qiu, Ling},
title = {Development and Validation of a Rapid Liquid Chromatography–Tandem Mass Spectrometry Method for the Quantitation of Vitamin K Metabolites in Different Matrices},
journal = {Journal of Mass Spectrometry},
year = {2025},
doi = {10.1002/jms.5120}
}
EUVIMED